Bharat Biotech#39;s Covaxin found to be safe, induced immune response in Phase-1

The overall incidence of #39;adverse events#39; was 14–21 percent in all vaccine-treated groups, says the data published in Lancet. The company says the incidence of adverse events are noticeably lower than the rates for other SARS-CoV-2 vaccine platform candidates.

from Moneycontrol Business News https://ift.tt/36khD6T